Rosenberg Robert, Herrmann Ken, Gertler Ralf, Künzli Beat, Essler Markus, Lordick Florian, Becker Karen, Schuster Tibor, Geinitz Hans, Maak Matthias, Schwaiger Markus, Siewert Jörg-Rüdiger, Krause Bernd
Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München, Ismaningerstr. 22, 81675, Munich, Germany.
Int J Colorectal Dis. 2009 Feb;24(2):191-200. doi: 10.1007/s00384-008-0616-8. Epub 2008 Dec 3.
To evaluate the value of positron emission tomography using fluorodeoxyglucose and computer tomography scan (FDG-PET/CT) for prediction of histopathological response of preoperative radiochemotherapy (RCTX) in patients with rectal carcinoma.
Thirty patients with uT3 rectal carcinoma were examined by FDG-PET/CT at baseline, 14 days after initiation, and after completion of preoperative RCTX. The FDG decreases seen with PET scanning from baseline to day 14 (early metabolic response) and after completion of therapy (late metabolic response) were compared with histopathological tumor response. One patient denied surgery after RCTX.
The mean (+/-SD) reduction of tumor FDG uptake in histopathologically responding compared to non-responding tumors was -44.3% (+/-20.1%) versus -29.6% (+/-13.1%) (p = 0.085) at day 14 and -66.0% (+/-20.3%) versus -48.3% (+/-23.4%) (p = 0.040) after completion of RCTX. Best differentiation of histopathological tumor response was achieved by a cut-off value of 35% reduction of initial FDG uptake at day 14 and 57.5% after completion of therapy. Applying the cut-off values as a criterion for metabolic response, histopathological response was predicted with a sensitivity of 74% (14/19) at day 14 and 79% (15/19) after completion of therapy. The positive predictive value for early metabolic response was 82% (14/17) and for late metabolic response was 83% (15/18). Histopathological evidence of accumulated peritumoral inflammation cells was associated with a minor FDG decrease in five histopathologically responding patients, and influenced the results with negative predictive values of 58% (7/12) and 64% (7/11) at the early and late time points, respectively.
Metabolic response to a preoperative RCTX using FDG-PET/CT in rectal cancer patients can be correlated with histopathological response, but FDG uptake of peritumoral inflammation cells limited the results and led to false negative results.
评估使用氟脱氧葡萄糖正电子发射断层扫描和计算机断层扫描(FDG-PET/CT)预测直肠癌患者术前放化疗(RCTX)组织病理学反应的价值。
对30例uT3期直肠癌患者在基线、开始治疗14天后以及术前RCTX完成后进行FDG-PET/CT检查。将PET扫描从基线到第14天(早期代谢反应)以及治疗完成后(晚期代谢反应)观察到的FDG降低情况与组织病理学肿瘤反应进行比较。1例患者在RCTX后拒绝手术。
在第14天,组织病理学有反应的肿瘤与无反应的肿瘤相比,肿瘤FDG摄取的平均(±标准差)降低分别为-44.3%(±20.1%)和-29.6%(±13.1%)(p = 0.085);在RCTX完成后分别为-66.0%(±20.3%)和-48.3%(±23.4%)(p = 0.040)。通过在第14天初始FDG摄取降低35%以及治疗完成后降低57.5%的临界值,可实现对组织病理学肿瘤反应的最佳区分。将这些临界值作为代谢反应的标准,在第14天预测组织病理学反应的敏感性为74%(14/19),治疗完成后为79%(15/19)。早期代谢反应的阳性预测值为82%(14/17),晚期代谢反应的阳性预测值为83%(15/18)。在5例组织病理学有反应的患者中,肿瘤周围炎症细胞聚集的组织病理学证据与较小的FDG降低相关,并且在早期和晚期时间点分别以58%(7/12)和64%(7/11)的阴性预测值影响结果。
直肠癌患者术前使用FDG-PET/CT进行RCTX的代谢反应与组织病理学反应相关,但肿瘤周围炎症细胞的FDG摄取限制了结果并导致假阴性结果。